Ann: Clinical Trial Preliminary Outcomes, page-107

Over double the previous highest volume on the ASX, not too shabby..

Not to compare to RAP, but I remember selling out about 20c after buying at 8c, thinking this is going to be dumped. It went up to 50c (200m+ MC). This is at 29m market cap, but can already sell in Europe because of the CE mark, and Australia with TGA registration. This is the first legitimate study by a well respected US Doctor. 50m m cap pre results in December, and anything north of 100m post (successfully results).

In short, don't panic about the 100% gain, it was priced as a failure. We have just received news which fundamentally changes this stock and risk profile.